Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium

Circulation

Volumn 114, Issue 11, 2006, Pages 1151-1158

  Smith, Craig S ^a   Bottomley, Paul A ^a   Schulman, Steven P ^a   Gerstenblith, Gary ^a   Weiss, Robert G ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Adenosine triphosphate; Creatine kinase; Heart failure; Hypertrophy; Magnetic resonance spectroscopy; Metabolism

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CREATINE KINASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; ENERGY RESOURCE; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTROPHY; KINETICS; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; CARDIAC OUTPUT, LOW; CREATINE KINASE; DISEASE PROGRESSION; ENERGY METABOLISM; FEMALE; HEART; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MYOCARDIUM; SEVERITY OF ILLNESS INDEX;

EID: 33748668461     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.613646     Document Type: Article

References (51)

1. Grossman W. Cardiac hypertrophy: useful adaptation or pathologic process? Am J Med. 1980;69:576-584.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.
3. Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann Rev Physiol. 1974;36:413-459.
4. Ingwall JS, Kramer MF, Fifer MA, Lorell BH, Shemin R, Grossman W, Allen PD. The creatine kinase system in normal and diseased human myocardium. N Engl J Med. 1985;313:1050-1054.
5. Wallimann T. Bioenergetics: dissecting the role of creatine kinase. Curr Biol. 1994;4:42-46.
6. Massie B, Schaefer S, Garcia J, McKirnan MD, Schwartz GG, Wisneski JA, Weiner MW, White FC. Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. Circulation. 1995;91:1814-1823.
7. Ye Y, Gong G, Ochiai K, Liu J, Zhang J. High-energy phosphate metabolism and creatine kinase in failing hearts: a new porcine model. Circulation. 2001;103:1570-1576.
8. 31P magnetic resonance spectroscopy. Lancet. 1991;338:973-976.
9. 31P MRS. Magn Res Med. 1998;39:772-782.
10. Lamb HJ, Beyerbacht HP, van der Laarse A, Stoel BC, Doornbos J, van der Wall EE, de Roos A. Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation. 1999;99:2261-2267.
11. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J. 1991;122:795-801.
12. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: altered cardiac high-energy phosphate metabolism in heart failure. Circulation. 1992;86:1810-1818.
13. 31P-NMR surface coil studies in living rat. Circ Res. 1987;60:871-878.
14. Smith SH, Kramer MF, Reis I, Bishop SP, Ingwall JS. Regional changes in creatine kinase and myocyte size in hypertensive and nonhypertensive cardiac hypertrophy. Circ Res. 1990;67:1334-1344.
15. Ye Y, Wang C, Zhang J, Cho YK, Gong G, Murakami Y, Bache RJ. Myocardial creatine kinase kinetics and isoform expression in hearts with severe LVH hypertrophy. Am J Physiol. 2001;281:H376-H386.
16. Gong G, Liu J, Liang P, Guo T, Hu Q, Ochiai K, Hou M, Ye Y, Wu X, Mansoor A, From AH, Ugurbil K, Bache RJ, Zhang J. Oxidative capacity in failing hearts. Am J Physiol. 2003;285:H541-H548.
17. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction. J Am Coll Cardiol. 1999;33:1948-1955.
18. Weiss RG, Gerstenblith G, Bottomley PA. ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A. 2005;102:808-813.
19. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N Engl J Med. 1971;285:1441-1446.
20. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004;43:317-327.
21. Bottomley PA, Ouwerkerk R, Lee RF, Weiss RG. The four-angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo. Magn Reson Med. 2002;47:850-863.
22. Bottomley PA, Atalar E, Weiss RG. Human cardiac high-energy phosphate metabolite concentrations by 1D-resolved NMR spectroscopy. Magn Reson Med. 1996;35:664-670.
23. Bottomley PA, Hardy CJ, Roemer PB. Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance. Magn Reson Med. 1990;14:425-434.
24. 31P magnetic resonance spectroscopy. Circulation. 1995;92:15-23.
25. Laine H, Katoh C, Luotolahti M, Yki-Jarvinen H, Kantola I, Jula A, Takala TO, Ruotsalainen U, Iida H, Haaparanta J, Nuutila P, Knuuti J. Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy. Circulation. 1999;100:2425-2430.
26. Bache RJ, Zhang J, Murakami Y, Zhang Y, Cho YK, Merkle H, Gong G, From AH, Ugurbil K. Myocardial oxygenation at high workstates in hearts with left ventricular hypertrophy. Cardiovasc Res. 1999;42:616-626.
27. Saupe KW, Spindler M, Hopkins JAC, Shen W, Ingwall JS. Kinetic, thermodynamic, and developmental consequences of deleting creatine kinase isoenzymes from the heart. J Biol Chem. 2000;275:19742-19746.
28. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation. 1998;97:2536-2542.
29. Bottomley PA. MR spectroscopy of the human heart: the status and the challenges. Radiology. 1994;191:593-612.
30. 31P SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol. 2002;40:1267-1274.
31. Bittl JA, Ingwall JS. Intracellular high-energy phosphate transfer in normal and hypertrophied myocardium. Circulation. 1987;74(suppl I):I-96-I-101.
32. Nakae I, Mitsunami K, Omura T, Yabe T, Tsutamoto T, Matsuo S, Takahashi M, Morikawa S, Inubushi T, Nakamura Y, Kinoshita M, Horie M. Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol. 2003;42:1587-1593.
33. 31P NMR surface coil studies in brain, heart and skeletal muscle of the living rat. Biochemistry. 1987;26:6083-6090.
34. Zweier JL, Jacobus WE, Korecky B, Brandejs-Barry Y. Bioenergetic consequences of cardiac phosphocreatine depletion induced by creatine analogue feeding. J Biol Chem. 1991;266:20296-20304.
35. Horn M, Remkes H, Stromer H, Dienesch C, Neubauer S. Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction. Circulation. 2001;104:1844-1849.
36. Crozatzier B, Badoul T, Boehm E, Ennezat PV, Guenoun T, Su J, Veksler V, Hittinger L, Ventura-Clapier R. Role of creatine kinase in cardiac excitation-contraction coupling: studies in creatine kinase-deficient mice. FASEB J. 2002;16:653-660.
37. Spindler M, Meyer K, Stromer H, Leupold A, Boehm E, Wagner H, Neubauer S. Creatine kinase-deficient hearts exhibit increased susceptibility to ischemia-reperfusion injury and impaired calcium homeostasis. Am J Physiol. 2004;287:H1039-H1045.
38. Kaasik A, Veksler V, Boehm E, Novotova M, Minajeva A, Ventura-Clapier R. Energetic crosstalk between organelles: architectural integration of energy production and utilization. Circ Res. 2001;89:153-159.
39. Dzeja PP, Terzic A. Phosphotransfer networks and cellular energetics. J Exp Biol. 2003;206:2039-2047.
40. Ogut O, Brozovich FV. Creatine phosphate consumption and the actomyosin crossbridge cycle in cardiac muscles. Circ Res. 2003;93:54-60.
41. 31P NMR spectroscopy. Magn Reson Med. 1990;16:91-116.
42. 31P nuclear magnetic resonance. Am J Physiol. 1986;251:H171-H175.
43. Bottomley PA, Herfkens RJ, Smith LS, Bashore TM. Altered phosphate metabolism in myocardial infarction: P-31 MR spectroscopy. Radiology. 1987;165:703-707.
44. Sun KT, Yeatman LA, Buxton DB, Chen K, Johnson JA, Huang S-C, Kofoed KF, Weismueller S, Czernin J, Phelps ME, Schelbert H. Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon11]acetate. J Nucl Med. 1998;39:272-280.
45. Ganz W, Tamura K, Marcus HS, Ronoso R, Yoshida S, Swan HJC. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation. 1971;44:181-195.
46. Monroe RG. Myocardial oxygen consumption during ventricular contraction and relaxation. Circ Res. 1964;14:294-300.
47. Gibbs CL, Wendt IR, Kotsanas G, Young IR. The energy cost of relaxation in control and hypertrophic rabbit papillary muscles. Heart Vessels. 1990;5:198-205.
48. Shulman RG, Rothman DL. Lactate, glycogen and fatigue. In: Shulman RG, Rothman DL, eds. Metabolomics by In Vivo NMR. West Sussex, England: Wiley & Sons; 2005.
49. Liao R, Jain M, Cui L, D'Agostino L, Aiello F, Luptak I, Ngoy S, Mortensen RM, Tian R. Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation. 2003;106:2125-2131.
50. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 2003;65:45-79.
51. Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation. 2005;111:2837-2849.